Kura Oncology
(NASDAQ:KURA)
12.00
0.10[0.84%]
Last update: 11:06AM
15 minutes delayed
Day High/Low11.36 - 12.03
52 Week High/Low10.41 - 25.22
Open / Close11.86 / -
Float / Outstanding65.3M / 66.6M
Vol / Avg.80.1K / 633.7K
Mkt Cap799.6M
P/E-
50d Avg. Price15
Div / Yield-
Payout Ratio-
EPS-0.49
Total Float65.3M

Kura Oncology (NASDAQ:KURA), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$35.00

Lowest Price Target1

$27.00

Consensus Price Target1

$30.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
40000

Analyst Firms Making Recommendations1

  • Credit Suisse
  • SVB Leerink
  • Jefferies
  • HC Wainwright & Co.

1calculated from analyst ratings published within the last 6 months

Analyst Ratings for Kura Oncology

All Ratings (0)

Upgrades (0)

Downgrades (0)

Initiations (0)

date
Upside/Downside
Analyst Firm
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
No Data

Kura Oncology Questions & Answers

Q
What is the target price for Kura Oncology (KURA)?
A

The latest price target for Kura Oncology (NASDAQ: KURA) was reported by Credit Suisse on February 25, 2022. The analyst firm set a price target for $27.00 expecting KURA to rise to within 12 months (a possible 125.00% upside). 7 analyst firms have reported ratings in the last year.

Q
What is the most recent analyst rating for Kura Oncology (KURA)?
A

The latest analyst rating for Kura Oncology (NASDAQ: KURA) was provided by Credit Suisse, and Kura Oncology maintained their outperform rating.

Q
When is the next analyst rating going to be posted or updated for Kura Oncology (KURA)?
A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kura Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kura Oncology was filed on February 25, 2022 so you should expect the next rating to be made available sometime around February 25, 2023.

Q
Is the Analyst Rating Kura Oncology (KURA) correct?
A

While ratings are subjective and will change, the latest Kura Oncology (KURA) rating was a maintained with a price target of $25.00 to $27.00. The current price Kura Oncology (KURA) is trading at is $12.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.